Presentation is loading. Please wait.

Presentation is loading. Please wait.

Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into.

Published byNaomi Rodgers Modified over 5 years ago

Similar presentations

Presentation on theme: "Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into."— Presentation transcript:

1 Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into the abdominal aorta in rabbits  Haitong Liu, Binbin Chen, MD, Shitong Li, MD, Junyan Yao, PhD  Journal of Vascular Surgery  Volume 63, Issue 4, Pages (April 2016) DOI: /j.jvs Copyright © 2016 Society for Vascular Surgery Terms and Conditions

2 Fig 1 Neurologic scores are shown at 1, 6, 24, 48, and 72 hours after reperfusion. In the normal saline (NS) group and in the delta-opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE; D) groups D0.0005, D0.005, D0.05, and D0.5 mg/kg (each n = 8), the animals received spinal cord ischemia for 30 minutes with NS or DADLE infused through the abdominal aorta during the entire period of spinal cord ischemia. The sham group (n = 6) did not receive spinal cord ischemia. Tarlov scores in the DADLE treatment group were significantly higher than in the NS group (P < .05). The score in the D0.05 group was the highest among all of the DADLE treatment groups (P < .05). *P < .05 vs NS. #P < .05 vs D0.05. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions

3 Fig 2 Rates of paraplegia are shown at 1, 6, 24, 48, and 72 hours after reperfusion. The animals in the normal saline (NS), and in the delta-opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE; D) D0.0005, D0.005, D0.05, and D0.5 mg/kg groups (each n = 8) received spinal cord ischemia for 30 minutes with NS or DADLE infused through abdominal aorta during the entire spinal cord ischemic period. The sham group (n = 6) did not receive spinal cord ischemia. The rates in the DADLE treatment groups were significantly lower compared with the NS group (P < .05). The rate in D0.05 group was the lowest among all of the DADLE treatment groups (P < .05). *P < .05 vs NS. #P < .05 vs D0.05. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions

4 Fig 3 Representative photomicrographs show the ventral horn of the spinal cord at 72 hours after reperfusion in the (A) normal saline (NS), delta-opioid peptide [D-Ala2, D-Leu5] enkephalin (DADLE; D) (B) D0.0005, (C) D0.005, (D) D0.05, (E) D0.5 mg/kg, and (F) sham (hematoxylin and eosin stain; original magnification ×40). G, The number of surviving motor neurons in the six groups is shown at 72 hours after reperfusion. The error bars show the interquartile range. *P < .05 vs NS. Journal of Vascular Surgery  , DOI: ( /j.jvs ) Copyright © 2016 Society for Vascular Surgery Terms and Conditions

Download ppt "Dose-dependent neuroprotection of delta-opioid peptide [D-Ala2, D-Leu5] enkephalin on spinal cord ischemia-reperfusion injury by regional perfusion into."

Similar presentations

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages 1072-1082 (October 2014) DOI:

Professionalism and the work-life balance Thomas S. Huber, MD, PhD Journal of Vascular Surgery Volume 60, Issue 4, Pages (October 2014) DOI:
Resveratrol, a Natural Red Wine Polyphenol, Reduces Ischemia-Reperfusion–Induced Spinal Cord Injury  Sadi Kaplan, MD, Gianluigi Bisleri, MD, Jeffrey A.

Resveratrol, a Natural Red Wine Polyphenol, Reduces Ischemia-Reperfusion–Induced Spinal Cord Injury  Sadi Kaplan, MD, Gianluigi Bisleri, MD, Jeffrey A.
Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities  Apostolos K. Tassiopoulos, MD,

Role of nitric oxide and tumor necrosis factor on lung injury caused by ischemia/reperfusion of the lower extremities  Apostolos K. Tassiopoulos, MD,
Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia  Marshall T. Bell, MD, Viktor.

Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia  Marshall T. Bell, MD, Viktor.
Jeanwan Kang, MD, Hassan Albadawi, MD, Patrick J. Casey, MD, Thomas A

Jeanwan Kang, MD, Hassan Albadawi, MD, Patrick J. Casey, MD, Thomas A
Inhibition of micro-ribonucleic acid-320 attenuates neurologic injuries after spinal cord ischemia  Fang He, MD, Enyi Shi, MD, PhD, Lihui Yan, MD, Juchen.

Inhibition of micro-ribonucleic acid-320 attenuates neurologic injuries after spinal cord ischemia  Fang He, MD, Enyi Shi, MD, PhD, Lihui Yan, MD, Juchen.
Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion  Marshall T. Bell, MD,

Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion  Marshall T. Bell, MD,
Therapeutic distant organ effects of regional hypothermia during mesenteric ischemia- reperfusion injury  Rachel J. Santora, MD, Mihaela L. Lie, MD, Dmitry.

Therapeutic distant organ effects of regional hypothermia during mesenteric ischemia- reperfusion injury  Rachel J. Santora, MD, Mihaela L. Lie, MD, Dmitry.
Early ischemic preconditioning without hypotension prevents spinal cord injury caused by descending thoracic aortic occlusion  Ioannis K. Toumpoulis,

Early ischemic preconditioning without hypotension prevents spinal cord injury caused by descending thoracic aortic occlusion  Ioannis K. Toumpoulis,
Superiority of early relative to late ischemic preconditioning in spinal cord protection after descending thoracic aortic occlusion  Ioannis K. Toumpoulis,

Superiority of early relative to late ischemic preconditioning in spinal cord protection after descending thoracic aortic occlusion  Ioannis K. Toumpoulis,
Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia  Enyi Shi, MD, PhD, Xiaojing.

Controlled low-pressure perfusion at the beginning of reperfusion attenuates neurologic injury after spinal cord ischemia  Enyi Shi, MD, PhD, Xiaojing.
Ischemic postconditioning protects the spinal cord from ischemia–reperfusion injury via modulation of redox signaling  Wenying Song, MD, Jing Sun, MD,

Ischemic postconditioning protects the spinal cord from ischemia–reperfusion injury via modulation of redox signaling  Wenying Song, MD, Jing Sun, MD,
Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins  Renate R. van den Bos, MD, Rene Milleret, MD, Martino.

Proof-of-principle study of steam ablation as novel thermal therapy for saphenous varicose veins  Renate R. van den Bos, MD, Rene Milleret, MD, Martino.
Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury.

Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury.
Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps  Francesca Polito, PhD, Alessandra Bitto, MD, PhD, Mariarosaria.

Polydeoxyribonucleotide restores blood flow in an experimental model of ischemic skin flaps  Francesca Polito, PhD, Alessandra Bitto, MD, PhD, Mariarosaria.
Ethyl pyruvate modulates delayed paralysis following thoracic aortic ischemia reperfusion in mice  Bao-Ngoc Nguyen, MD, Hassan Albadawi, MD, Rahmi Oklu,

Ethyl pyruvate modulates delayed paralysis following thoracic aortic ischemia reperfusion in mice  Bao-Ngoc Nguyen, MD, Hassan Albadawi, MD, Rahmi Oklu,
Reduction of ischemic spinal cord injury by dextrorphan: Comparison of several methods of administration  Hitoshi Terada, MD, Teruhisa Kazui, MD, Makoto.

Reduction of ischemic spinal cord injury by dextrorphan: Comparison of several methods of administration  Hitoshi Terada, MD, Teruhisa Kazui, MD, Makoto.
Protective use of N-methyl-d-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity  Yasunori Cho, MD, Toshihiko.

Protective use of N-methyl-d-aspartate receptor antagonists as a spinoplegia against excitatory amino acid neurotoxicity  Yasunori Cho, MD, Toshihiko.
Veysel Kutay, MD, Cevat Yakut, MD, Hasan Ekim, MD 

Veysel Kutay, MD, Cevat Yakut, MD, Hasan Ekim, MD 
Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits  Hironori Baba, MD, Yoshihisa Tanoue, MD, PhD, Taketoshi.

Protective effects of cold spinoplegia with fasudil against ischemic spinal cord injury in rabbits  Hironori Baba, MD, Yoshihisa Tanoue, MD, PhD, Taketoshi.

Similar presentations

Ads by Google